USD 55.03
(-2.01%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -1.63 Million USD | 94.41% |
2022 | -29.26 Million USD | -397.43% |
2021 | 9.84 Million USD | -28.64% |
2020 | 13.78 Million USD | 823.03% |
2019 | -1.9 Million USD | 81.22% |
2018 | -10.15 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -18.36 Million USD | 41.41% |
2024 Q1 | -24.2 Million USD | -418.58% |
2024 Q2 | -31.34 Million USD | -29.53% |
2023 Q4 | -4.66 Million USD | -247.6% |
2023 FY | -1.63 Million USD | 94.41% |
2023 Q3 | 3.16 Million USD | 51.65% |
2023 Q2 | 2.08 Million USD | 194.0% |
2023 Q1 | -2.21 Million USD | 61.75% |
2022 Q2 | -10.18 Million USD | -220.75% |
2022 Q1 | -3.17 Million USD | -386.9% |
2022 FY | -29.26 Million USD | -397.43% |
2022 Q4 | -5.79 Million USD | 42.89% |
2022 Q3 | -10.15 Million USD | 0.33% |
2021 Q3 | -2.8 Million USD | -168.93% |
2021 Q2 | 4.06 Million USD | -45.53% |
2021 FY | 9.84 Million USD | -28.64% |
2021 Q1 | 7.46 Million USD | 6.93% |
2021 Q4 | 1.1 Million USD | 139.48% |
2020 Q4 | 6.98 Million USD | 7.53% |
2020 Q3 | 6.49 Million USD | 270.77% |
2020 FY | 13.78 Million USD | 823.03% |
2020 Q2 | -3.8 Million USD | -192.52% |
2020 Q1 | 4.11 Million USD | 1057.6% |
2019 Q2 | -965 Thousand USD | -1.76% |
2019 FY | -1.9 Million USD | 81.22% |
2019 Q1 | -948.31 Thousand USD | 0.0% |
2019 Q4 | 355.17 Thousand USD | -2.96% |
2019 Q3 | 366 Thousand USD | 137.93% |
2018 FY | -10.15 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Acutus Medical, Inc. | -81.66 Million USD | 97.997% |
Axonics, Inc. | -6.08 Million USD | 73.127% |
INVO Bioscience, Inc. | -8.03 Million USD | 79.638% |
CVRx, Inc. | -41.19 Million USD | 96.029% |
iRhythm Technologies, Inc. | -123.4 Million USD | 98.674% |
Monogram Orthopaedics, Inc. | -13.74 Million USD | 88.098% |
MaxCyte, Inc. | -37.92 Million USD | 95.686% |
ClearPoint Neuro, Inc. | -22.08 Million USD | 92.594% |
PROCEPT BioRobotics Corporation | -105.89 Million USD | 98.455% |
Sintx Technologies, Inc. | -8.25 Million USD | 80.191% |
Accelerate Diagnostics, Inc. | -61.61 Million USD | 97.345% |
Apyx Medical Corporation | -18.71 Million USD | 91.257% |
Cutera, Inc. | -162.83 Million USD | 98.995% |
Helius Medical Technologies, Inc. | -8.85 Million USD | 81.514% |
NeuroPace, Inc. | -32.95 Million USD | 95.036% |
IRIDEX Corporation | -9.57 Million USD | 82.905% |
Tactile Systems Technology, Inc. | 28.51 Million USD | 105.737% |
enVVeno Medical Corporation | -23.51 Million USD | 93.043% |
TELA Bio, Inc. | -46.66 Million USD | 96.494% |
Tandem Diabetes Care, Inc. | -222.61 Million USD | 99.265% |
UFP Technologies, Inc. | 44.92 Million USD | 103.642% |
Modular Medical, Inc. | -17.47 Million USD | 90.635% |
STRATA Skin Sciences, Inc. | -10.83 Million USD | 84.894% |
LENSAR, Inc. | -14.38 Million USD | 88.625% |
Integra LifeSciences Holdings Corporation | 67.74 Million USD | 102.415% |
Surmodics, Inc. | -11.54 Million USD | 85.826% |
Vivos Therapeutics, Inc. | -13.58 Million USD | 87.956% |
Inogen, Inc. | -102.44 Million USD | 98.403% |
Tivic Health Systems, Inc. | -8.24 Million USD | 80.155% |
RxSight, Inc. | -48.6 Million USD | 96.634% |
Nexalin Technology, Inc. | -4.64 Million USD | 64.807% |
Lucid Diagnostics Inc. | -52.66 Million USD | 96.894% |
Nano-X Imaging Ltd. | -60.77 Million USD | 97.308% |
Nexalin Technology, Inc. | -4.64 Million USD | 64.807% |
PetVivo Holdings, Inc. | -10.95 Million USD | 85.067% |
Cytek Biosciences, Inc. | -12.14 Million USD | 86.533% |
Alphatec Holdings, Inc. | -186.63 Million USD | 99.123% |
Rapid Micro Biosystems, Inc. | -52.46 Million USD | 96.882% |
Dynatronics Corporation | -2.69 Million USD | 39.356% |
TriSalus Life Sciences, Inc. | -59.03 Million USD | 97.229% |
InMode Ltd. | 197.91 Million USD | 100.827% |
Bruker Corporation | 427.2 Million USD | 100.383% |
Movano Inc. | -29.28 Million USD | 94.413% |
Orthofix Medical Inc. | -151.39 Million USD | 98.919% |
FONAR Corporation | 10.56 Million USD | 115.482% |
BioSig Technologies, Inc. | -29.04 Million USD | 94.367% |
Envoy Medical, Inc. | -29.9 Million USD | 94.53% |
Align Technology, Inc. | 445.05 Million USD | 100.368% |
Anika Therapeutics, Inc. | -82.66 Million USD | 98.021% |
Talis Biomedical Corporation | -62 Million USD | 97.362% |
Cerus Corporation | -37.48 Million USD | 95.636% |
908 Devices Inc. | -36.39 Million USD | 95.505% |
Nemaura Medical Inc. | -14.14 Million USD | 88.433% |
Outset Medical, Inc. | -172.79 Million USD | 99.053% |
NanoVibronix, Inc. | -3.71 Million USD | 55.915% |
Venus Concept Inc. | -37.25 Million USD | 95.608% |
Telesis Bio, Inc. | -47.72 Million USD | 96.572% |
Treace Medical Concepts, Inc. | -49.52 Million USD | 96.697% |
Quipt Home Medical Corp. | -2.78 Million USD | 41.236% |
IRadimed Corporation | 17.19 Million USD | 109.516% |
Tenon Medical, Inc. | -15.58 Million USD | 89.5% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 85.504% |
Pulmonx Corporation | -60.84 Million USD | 97.311% |
iCAD, Inc. | -4.84 Million USD | 66.247% |
QT Imaging Holdings, Inc. | -5.13 Million USD | 68.124% |
NeuroOne Medical Technologies Corporation | -11.85 Million USD | 86.205% |
Viemed Healthcare, Inc. | 10.24 Million USD | 115.972% |
SI-BONE, Inc. | -43.33 Million USD | 96.225% |
Semler Scientific, Inc. | 20.58 Million USD | 107.948% |
Biotricity, Inc. | -14.09 Million USD | 88.392% |
Cytosorbents Corporation | -28.5 Million USD | 94.261% |
DexCom, Inc. | 541.5 Million USD | 100.302% |
ZimVie Inc. | -393.28 Million USD | 99.584% |
Aethlon Medical, Inc. | -12.2 Million USD | 86.599% |
DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 355.547% |
IceCure Medical Ltd | -14.65 Million USD | 88.834% |
PAVmed Inc | -64.17 Million USD | 97.451% |
Sight Sciences, Inc. | -55.54 Million USD | 97.055% |
Insulet Corporation | 206.3 Million USD | 100.793% |
Profound Medical Corp. | -28.56 Million USD | 94.274% |
electroCore, Inc. | -18.83 Million USD | 91.314% |
Bioventus Inc. | -156.23 Million USD | 98.953% |
InspireMD, Inc. | -19.91 Million USD | 91.785% |
PAVmed Inc. | -64.17 Million USD | 97.451% |
Nuwellis, Inc. | -20.2 Million USD | 91.905% |
OrthoPediatrics Corp. | -20.97 Million USD | 92.2% |
DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 355.547% |
BrainsWay Ltd. | -4.19 Million USD | 61.02% |
BIOLASE, Inc. | -20.63 Million USD | 92.071% |
Beyond Air, Inc. | -60.24 Million USD | 97.284% |
AxoGen, Inc. | -21.71 Million USD | 92.466% |
Heart Test Laboratories, Inc. | -6.6 Million USD | 75.232% |
Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 89.395% |
AdaptHealth Corp. | -678.89 Million USD | 99.759% |
Quanterix Corporation | -32.33 Million USD | 94.94% |
Viveve Medical, Inc. | -22.02 Million USD | 92.573% |
LivaNova PLC | 17.54 Million USD | 109.324% |
Co-Diagnostics, Inc. | -35.33 Million USD | 95.37% |
Varex Imaging Corporation | -47.7 Million USD | 96.57% |
Vivani Medical, Inc. | -25.65 Million USD | 93.622% |
ReShape Lifesciences Inc. | -11.38 Million USD | 85.633% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 85.504% |
Sensus Healthcare, Inc. | 485 Thousand USD | 437.32% |
Pacific Biosciences of California, Inc. | -306.73 Million USD | 99.467% |
TransMedics Group, Inc. | -25.02 Million USD | 93.463% |
ReWalk Robotics Ltd. | -22.13 Million USD | 92.608% |
NeuroMetrix, Inc. | -6.52 Million USD | 74.944% |
Spectral AI, Inc. | -20.85 Million USD | 92.155% |
Hyperfine, Inc. | -44.23 Million USD | 96.302% |
Establishment Labs Holdings Inc. | -78.5 Million USD | 97.916% |
Biomerica, Inc. | -5.97 Million USD | 72.633% |
Bone Biologics Corporation | -8.94 Million USD | 81.718% |
AVITA Medical, Inc. | -39.16 Million USD | 95.823% |
Bluejay Diagnostics, Inc. | -9.95 Million USD | 83.564% |
Silk Road Medical, Inc | -55.74 Million USD | 97.065% |